Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events

Go back to Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 1.02 +0.28 (37.84%)
Previous Close $0.74    52 Week High $0.00 
Open $0.74    52 Week Low $0.00 
Day High $1.05    P/E N/A 
Day Low $0.71    EPS $0.00 
Volume 6,663,311